p21WAF1/CIP1 is more effective than p53 in growth suppression of mouse renal carcinoma cell line Renca in vitro and in vivo (Q45071985)

9 December 2017

p21WAF1/CIP1 is more effective than p53 in growth suppression of mouse renal carcinoma cell line Renca in vitro and in vivo (English)

1 reference

9 December 2017

1 reference

Marijeta Kralj

1

1 reference

PubMed ID

12884025

9 December 2017

Jasminka Pavelić

series ordinal

2

1 reference

9 December 2017

15 July 2003

1 reference

Journal of Cancer Research and Clinical Oncology

9 December 2017

1 reference

9 December 2017

129

1 reference

9 December 2017

8

1 reference

9 December 2017

463-471

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-003-0458-2

9 December 2017

0 references

cites work

Exogenous wt-p53 protein is active in transformed cells but not in their non-transformed counterparts: implications for cancer gene therapy without tumor targeting

1 reference

12 December 2020

Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts

1 reference

12 December 2020

High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus.

1 reference

12 December 2020

Development and application of adenoviral vectors for gene therapy of cancer

1 reference

12 December 2020

1 reference

12 December 2020

Overexpression of p21WAF1/CIP1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines.

1 reference

12 December 2020

Gene therapy for cancer: what have we done and where are we going?

1 reference

12 December 2020

Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle

1 reference

12 December 2020

Inhibition of pancreatic tumor cell growth in culture by p21WAF1 recombinant adenovirus.

1 reference

12 December 2020

Gene therapy for head and neck cancer. Comparing the tumor suppressor gene p53 and a cell cycle regulator WAF1/CIP1 (p21).

1 reference

12 December 2020

The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo

1 reference

12 December 2020

Efficacy of multiple administrations of a recombinant adenovirus expressing wild-type p53 in an immune-competent mouse tumor model

1 reference

12 December 2020

WAF1, a potential mediator of p53 tumor suppression

1 reference

12 December 2020

Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer

1 reference

12 December 2020

Effects of a recombinant adenovirus expressing WAF1/Cip1 on cell growth, cell cycle, and apoptosis.

1 reference

12 December 2020

Cytotoxic effects of recombinant adenovirus p53 and cell cycle regulator genes (p21 WAF1/CIP1 and p16CDKN4) in human prostate cancers

1 reference

12 December 2020

Up-regulated P21CIP1 expression is part of the regulation quantitatively controlling serum deprivation-induced apoptosis

1 reference

12 December 2020

Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts.

1 reference

12 December 2020

p21(WAF1/Cip1): more than a break to the cell cycle?

1 reference

12 December 2020

p21(WAF1/Cip1) retards the growth of human squamous cell carcinomas in vivo

1 reference

12 December 2020

Clinical implications of p53 mutations

1 reference

12 December 2020

Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen.

1 reference

12 December 2020

A rapid and simple method for the isolation of apoptotic DNA fragments.

1 reference

12 December 2020

p53 Signaling and cell cycle checkpoints

1 reference

12 December 2020

Effect of p21waf1/cip1 transgene on radiation induced apoptosis in T cells

1 reference

12 December 2020

p53-oriented cancer therapies: current progress

1 reference

12 December 2020

P53 tumor suppressor gene therapy for cancer

1 reference

12 December 2020

Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression

1 reference

12 December 2020

Adenovirus-mediated p21((WAF1/SDII/CIP1)) gene transfer induces apoptosis of human cervical cancer cell lines

1 reference

12 December 2020

Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell lines.

1 reference

12 December 2020

Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation

1 reference

12 December 2020

Induction of growth arrest and cell death by overexpression of the cyclin-Cdk inhibitor p21 in hamster BHK21 cells

1 reference

12 December 2020

1 reference

12 December 2020

CD95/Fas signaling in T lymphocytes induces the cell cycle control protein p21cip-1/WAF-1, which promotes apoptosis

1 reference

12 December 2020

In vivo gene therapy with p53 or p21 adenovirus for prostate cancer

1 reference

12 December 2020

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

1 reference

12 December 2020

Proliferation, cell cycle and apoptosis in cancer

1 reference

12 December 2020

Suppression of mammary carcinoma growth in vitro and in vivo by inducible expression of the Cdk inhibitor p21.

1 reference

12 December 2020

p21--negative regulator of the cell cycle

1 reference

12 December 2020

10.1007/S00432-003-0458-2

Identifiers

DOI

1 reference

PubMed ID

12884025

Dimensions Publication ID

9 December 2017

0 references

1 reference

PubMed ID

12884025